Chemotherapy and/or radiotherapy after surgery for ovarian carcinosarcoma
References
Additional references
Ariyoshi K, Kawauchi S, Kaku T, Nakano H, Tsuneyoshi M. Prognostic factors in ovarian carcinosarcoma: a clinicopathological and immunohistochemical analysis of 23 cases. Histopathology 2000;37(5):427‐36.
Barnholtz‐Sloan JS, Morris R, Malone JM, Jr, Munkarah AR. Survival of women diagnosed with malignant, mixed mullerian tumors of the ovary (OMMMT). Gynecologic Oncology 2004;93(2):506‐12.
Bicher A, Levenback C, Silva EG, Burke TW, Morris M, Gershenson DM. Ovarian malignant mixed mullerian tumors treated with platinum‐based chemotherapy. Obstetrics and Gynecology 1995;85(5 Pt 1):735‐9.
Brown E, Stewart M, Rye T, Al‐Nafussi A, Williams AR, et al. Carcinosarcoma of the ovary: 19 years of prospective data from a single center. Cancer 2004;100(10):2148‐53.
Carlson JA, Edwards C, Wharton JT, Gallager HS, Delclos L, Rutledge F. Mixed mesodermal sarcoma of the ovary. Treatment with combination radiation therapy and chemotherapy. Cancer 1983;52(8):1473‐7.
Duska LR, Garrett A, Eltabbakh GH, Oliva E, Penson R, Fuller AF. Paclitaxel and platinum chemotherapy for malignant mixed mullerian tumors of the ovary. Gynecologic Oncology 2002;85(3):459‐63.
Hanjani P, Petersen RO, Lipton SE, Nolte SA. Malignant mixed mesodermal tumors and carcinosarcoma of the ovary: report of eight cases and review of literature. Obstetrics and Gynecological Surveys 1983;38(9):537‐45.
Harris MA, Delap LM, Sengupta PS, Wilkinson PM, Welch RS, et al. Carcinosarcoma of the ovary. British Journal of Cancer 2003;88(5):654‐7.
Higgins JPT, Green S editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. In: The Cochrane Library, Issue 3, 2005. John Wiley & Son. Ltd, Chichester, UK, 2005.
Prendiville J, Murphy D, Renninson J, Buckley H, Crowther D. Carcinosarcoma of the ovary treated over a 10‐year period at the Christie Hospital. International Journal of Gynecological Cancer 1994;4(3):200‐5.
Russell PB, Solomon HJ. Malignant mullerian and miscellaneous mesenchymal tumors of ovary ('ovarian sarcomas'). In: Coppleson M editor(s). Gynecologic Oncology. 2nd Edition. Churchill Livingstone, 1992:971‐86.
Simon SR, Wang SE, Uhl M, Shackney S. Complete response of carcinosarcoma of the ovary to therapy with doxorubicin, ifosfamide, and dacarbazine. Gynecologic Oncology 1991;41(2):161‐6.
Tate Thigpen J, Blessing JA, DeGeest K, Look KY, Homesley HD. Cisplatin as initial chemotherapy in ovarian carcinosarcomas: a Gynecologic Oncology Group study. Gynecologic Oncology 2004;93(2):336‐9.
Terada KY, Johnson TL, Hopkins M, Roberts JA. Clinicopathologic features of ovarian mixed mesodermal tumors and carcinosarcomas. Gynecologic Oncology 1989;32(2):228‐32.
